EUVIMEDEUVIMED entdecken
Crossref

Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients

Yanan Cao, Yanqiu Ding, Jie Wang

American Journal of Hypertension · 2026

DOI: 10.1093/ajh/hpaf191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Yanan Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, State Grid Corporation of China Beijing Electric Power Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, MicroRNAs, Hypertension, Pregnancy-Induced. Die Arbeit nennt 34 Literaturangaben. Gefördert von: The Impact Mechanism and Risk Prediction of Clock Genes in Preeclampsia with Different Blood Pressure Patterns.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic hypertension, gestational hypertension (GH), and preeclampsia (PE) together comprise hypertensive disorders complicating pregnancy. They are one of the most common complications of pregnancy. Aberrant microRNA expression may signal PE and adverse outcomes.

Aims

Investigating the clinical significance of miR-590-5p in assessing the severity of PE and predicting adverse pregnancy outcomes.

Methods

A total of 240 subjects were enrolled in this study, including 60 patients with GH, 120 patients with PE, and 60 healthy controls. The PE group consisted of 60 mild PE (MP) and 60 severe PE (SP). The Quantitative reverse transcription PCR (RT-qPCR) was employed to detect the serum miR-590-5p expression. Receiver operating characteristic curves and logistic regression were used to analyze their diagnostic value. PE patients were grouped by miR-590-5p expression and followed until delivery. The Kaplan-Meier method was employed to investigate the influence of miR-590-5p expression on pregnancy outcome in patients with PE.

Results

MiR-590-5p expression was increased in GH, which was further elevated in PE. MiR-590-5p expression was shown to be greater in SP than in MP. MiR-590-5p could differentiate between GH/PE (area under the curve [AUC] = 0.921, sensitivity = 80.0%, specificity = 91.7%) and MP/SP (AUC = 0.910, sensitivity = 82.0%, specificity = 85.0%). The level of miR-590-5p expression was correlated positively with blood pressure, urinary protein, and creatinine, and negatively with platelets and neonatal weight. The miR-590-5p high-expression group of patients had a lower probability of normal delivery.

Conclusions

Upregulation of miR-590-5p might help to diagnose PE, depicting the severity of PE, and positively correlate with adverse pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaMicroRNAsHypertension, Pregnancy-InducedHumansFemalePregnancyAdultSeverity of Illness IndexCase-Control StudiesPregnancy OutcomeBiomarkersPredictive Value of TestsInfant, NewbornRisk Assessment

Stichwörter der Autor:innen

blood pressurehypertensionhypertensive disorders complicating pregnancymiR-590-5ppreeclampsiaprognosis

Substanzen

MicroRNAsMIRN590 microRNA, humanBiomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, State Grid Corporation of China Beijing Electric Power Hospital, Beijing, China.
  • Department of Ultrasound Medicine, Jinjiang Municipal Hospital, Jinjiang, China.
  • Department of Obstetrics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.

Förderung

  • The Impact Mechanism and Risk Prediction of Clock Genes in Preeclampsia with Different Blood Pressure Patterns

Zitieren

APA

Cao, Y., Ding, Y., & Wang, J. (2026). Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf191

Vancouver

Cao Y, Ding Y, Wang J. Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpaf191

BibTeX
@article{Cao2026,
  author = {Cao, Yanan and Ding, Yanqiu and Wang, Jie},
  title = {Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients},
  journal = {American Journal of Hypertension},
  year = {2026},
  doi = {10.1093/ajh/hpaf191}
}
Kostenlos starten →